These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Dofetilide: a review of its use in atrial fibrillation and atrial flutter. McClellan KJ; Markham A Drugs; 1999 Dec; 58(6):1043-59. PubMed ID: 10651390 [TBL] [Abstract][Full Text] [Related]
7. The emerging role of antiarrhythmic compounds with atrial selectivity in the management of atrial fibrillation. McBride BF J Clin Pharmacol; 2009 Mar; 49(3):258-67. PubMed ID: 19246727 [TBL] [Abstract][Full Text] [Related]
8. Pharmacological management of atrial fibrillation: an update. Hohnloser SH; Li YG; Bender B; Grönefeld G J Cardiovasc Pharmacol Ther; 2000 Jan; 5(1):11-6. PubMed ID: 10687669 [TBL] [Abstract][Full Text] [Related]
9. Rate control in atrial fibrillation: choice of treatment and assessment of efficacy. Boriani G; Biffi M; Diemberger I; Martignani C; Branzi A Drugs; 2003; 63(14):1489-509. PubMed ID: 12834366 [TBL] [Abstract][Full Text] [Related]
10. Vernakalant hydrochloride for the treatment of atrial fibrillation. Kozlowski D; Budrejko S; Lip GY; Mikhailidis DP; Rysz J; Raczak G; Banach M Expert Opin Investig Drugs; 2009 Dec; 18(12):1929-37. PubMed ID: 19938903 [TBL] [Abstract][Full Text] [Related]
11. Rate versus rhythm control in patients with atrial fibrillation: what the trials really say. Crijns HJ Drugs; 2005; 65(12):1651-67. PubMed ID: 16060699 [TBL] [Abstract][Full Text] [Related]
12. [Restoration and maintenance of sinus rhythm in patients with atrial fibrillation. New pharmacological approaches]. Runge S; Dietz R; Haverkamp W Dtsch Med Wochenschr; 2008 Dec; 133(49):2572-8. PubMed ID: 19039713 [TBL] [Abstract][Full Text] [Related]
13. New approaches to atrial fibrillation management: a critical review of a rapidly evolving field. Nattel S; Khairy P; Roy D; Thibault B; Guerra P; Talajic M; Dubuc M Drugs; 2002; 62(16):2377-97. PubMed ID: 12396229 [TBL] [Abstract][Full Text] [Related]
14. Review of contemporary antiarrhythmic drug therapy for maintenance of sinus rhythm in atrial fibrillation. Singla S; Karam P; Deshmukh AJ; Mehta J; Paydak H J Cardiovasc Pharmacol Ther; 2012 Mar; 17(1):12-20. PubMed ID: 21335483 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of vernakalant in recent-onset atrial fibrillation after the European medicines agency approval: systematic review and meta-analysis. Buccelletti F; Iacomini P; Botta G; Marsiliani D; Carroccia A; Gentiloni Silveri N; Franceschi F J Clin Pharmacol; 2012 Dec; 52(12):1872-8. PubMed ID: 22167572 [TBL] [Abstract][Full Text] [Related]
17. New pharmacological targets and treatments for atrial fibrillation. Carlsson L; Duker G; Jacobson I Trends Pharmacol Sci; 2010 Aug; 31(8):364-71. PubMed ID: 20605645 [TBL] [Abstract][Full Text] [Related]
18. The effects of rhythm control strategies versus rate control strategies for atrial fibrillation and atrial flutter: a protocol for a systematic review with meta-analysis and Trial Sequential Analysis. Sethi NJ; Safi S; Nielsen EE; Feinberg J; Gluud C; Jakobsen JC Syst Rev; 2017 Mar; 6(1):47. PubMed ID: 28264715 [TBL] [Abstract][Full Text] [Related]
19. Atrial fibrillation-the final frontier. Govindan M; Savelieva I; Catanchin A; Camm AJ J Cardiovasc Pharmacol Ther; 2010 Dec; 15(4 Suppl):36S-50S. PubMed ID: 20940451 [TBL] [Abstract][Full Text] [Related]
20. Low-dose amiodarone for atrial fibrillation. Middlekauff HR; Wiener I; Stevenson WG Am J Cardiol; 1993 Nov; 72(16):75F-81F. PubMed ID: 8237834 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]